NDAC/Endocrinologic Drug Joint Panel Meeting Likely To Focus On Statins
This article was originally published in The Tan Sheet
Executive Summary
A two-day joint meeting of the Nonprescription Drugs and Endocrinologic & Metabolic Drugs Advisory Committees is scheduled for Jan. 13-14, 2005